Dyadic (DYAI) Competitor Comparison
We are evaluating the key criteria listed to compare Dyadic (DYAI) against its competitors in the Biotechnology industry.
Market Capitalization
304 / 368Gross Profits
132 / 278Total Revenue
215 / 300EBITDA
0 / 337Free Cashflow
68 / 352Quick Ratio
160 / 357Earnings per Share
61 / 359Dividend yield
0 / 6Total Cash
329 / 358Performance 3 years
235 / 368Performance 5 years
250 / 368Performance 10 years
132 / 368Linearity 3 years
198 / 368Linearity 5 years
179 / 367Linearity 10 years
27 / 368Total Rank
311 / 368Dividend Rank
111 / 368Valuation Rank
203 / 368Piotroski Rank
274 / 368Muliplier Rank
332 / 368Valuation Rank - DYAI ranking 203 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.